Viewing Study NCT03606369

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-05-27 @ 2:36 AM
Study NCT ID: NCT03606369
Status: UNKNOWN
Last Update Posted: 2018-07-30
First Post: 2018-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.
Sponsor: Instituto Nacional de Cancerologia de Mexico
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasm View
None Antineoplastic Agents View
None Antiemetics View
None Quality of Life View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Neoplasm View
None Antiemetics View
None Quality of Life View
None Palonosetron View
None Ondansetron View